Skip to main content
. 2021 Jun 15;21:702. doi: 10.1186/s12885-021-08459-3

Table 4.

Incidence of adverse reactions

Variable Patients (N = 39)
Any grade, N (%) Grade 3 or 4, N (%)
Leukopenia 27 (73.0) 0 (0)
Granulocytopenia 29 (78.4) 0 (0)
Thrombocytopenia 6 (16.2) 1 (2.7)
Elevated transaminase 9 (24.3) 0 (0)
Hand-foot syndrome 9 (24.3) 0 (0)
Stomatitis 14 (37.8) 0 (0)
Fatigue 20 (54.1) 0 (0)
Proteinuria 4 (10.8) 0 (0)
Gastrointestinal hemorrhage 2 (5.4) 1 (2.7)
Hypertension 10 (27.0) 1 (2.7)
Neurotoxicity 10 (27.0) 0 (0)
Gastrointestinal perforation 1 (2.7) 1 (2.7)